Amazon on Track for Record High Close — Data Talk
Amazon.com, Inc. (AMZN) is currently at $187.03, up $1.96 or 1.06%
--Would be new all-time high (Based on available data back to May 15, 1997)
--Would be first new record close since July 8, 2021, when it closed at $186.57
--Currently up three of the past four days
--Currently up two consecutive days; up 3.91% over this period
--Best two day stretch since the two days ending Feb. 22, 2024, when it rose 4.49%
--Up 3.69% month-to-date
--Up 23.1% year-to-date
--Up 83.06% from 52 weeks ago (April 10, 2023), when it closed at $102.17
--Would be a new 52-week closing high
--Up 91.18% from its 52-week closing low of $97.83 on April 12, 2023
--Traded as high as $187.29; highest intraday level since Nov. 19, 2021, when it hit $188.11
--Up 1.2% at today's intraday high
--Sixth most active stock in the S&P 500 today
--Fifth most active stock in the Nasdaq 100 today
--Contributed 12.88 points to the DJIA so far today
All data as of 10:56:36 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 08, 2024 11:14 ET (15:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track